Latest medical trials contain demonstrated that phenylacetylglutamine (PAGln), a novel intestine microbial metabolite, can mechanistically modulate sufferers’ danger for creating heart problems (CVD) and coronary heart failure (HF). In a latest examine revealed within the Journal Researchers are investigating the mechanisms related to PAGln and opposed cardiovascular outcomes. Analysis into unique therapy choices for cardiovascular […]